Skip to main content

Table 3 Search strategya

From: Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis

Number

Searches

Results

Type

1

exp Breast Neoplasms/

241,242

Advanced

2

(breast? adj6 cancer*).mp,kw.

203,097

Advanced

3

(breast? adj6 neoplas*).mp,kw.

241,382

Advanced

4

(breast? adj6 carcin*).mp,kw.

62,218

Advanced

5

(breast? adj6 tumo?r*).mp,kw.

46,556

Advanced

6

(breast? adj6 adenocarcin*).mp,kw.

4642

Advanced

7

(breast? adj6 adeno-carcin*).mp,kw.

10

Advanced

8

(breast? adj6 sarcoma*).mp,kw.

1271

Advanced

9

(breast? adj6 dcis).mp,kw.

1258

Advanced

10

(breast? adj6 ductal).mp,kw.

16,064

Advanced

11

(breast? adj6 infiltrating).mp,kw.

1418

Advanced

12

(breast? adj6 intraductal).mp,kw.

2294

Advanced

13

(breast? adj6 lobular).mp,kw.

4044

Advanced

14

(breast? adj6 medullary).mp,kw.

383

Advanced

15

(breast? adj6 comedo*).mp,kw.

75

Advanced

16

(breast? adj6 metast*).mp,kw.

26,054

Advanced

17

(breast? adj2 malignan*).mp,kw.

4962

Advanced

18

(breast? adj6 onco*).mp,kw.

3338

Advanced

19

(mammar* adj6 cancer*).mp,kw.

5493

Advanced

20

(mammar* adj6 neoplas*).mp,kw.

21,985

Advanced

21

(mammar* adj6 carcin*).mp,kw.

11,584

Advanced

22

(mammar* adj6 tumo?r*).mp,kw.

18,026

Advanced

23

(mammar* adj6 adenocarcin*).mp,kw.

2958

Advanced

24

(mammar* adj6 adeno-carcin*).mp,kw.

3

Advanced

25

(mammar* adj6 sarcoma*).mp,kw.

384

Advanced

26

(mammar* adj6 ductal).mp,kw.

937

Advanced

27

(mammar* adj6 intraductal).mp,kw.

117

Advanced

28

(mammar* adj6 infiltrating).mp,kw.

201

Advanced

29

(mammar* adj6 lobular).mp,kw.

151

Advanced

30

(mammar* adj6 medullary).mp,kw.

19

Advanced

31

(mammar* adj6 comedo*).mp,kw.

6

Advanced

32

(mammar* adj6 metast*).mp,kw.

2554

Advanced

33

(mammar* adj6 malignan*).mp,kw.

1506

Advanced

34

(mammar* adj6 dcis).mp,kw.

61

Advanced

35

(ductal adj6 situ).mp,kw.

6301

Advanced

36

(ductal adj6 carcino*).mp,kw.

25,790

Advanced

37

(paget?? adj6 breast?).mp,kw.

367

Advanced

38

(paget?? adj6 nipple?).mp,kw.

363

Advanced

39

phyllodes.mp,kw.

1876

Advanced

40

phylloides.mp,kw.

206

Advanced

41

cystosarcoma*.mp,kw.

603

Advanced

42

DCIS.mp,kw.

3401

Advanced

43

or/1-40

318,397

Advanced

44

exp Ovarian Neoplasms/

71,707

Advanced

45

(ovar* adj6 cancer*).mp,kw.

44,037

Advanced

46

(ovar* adj6 neoplas*).mp,kw.

71,929

Advanced

47

(ovar* adj6 tumo?r*).mp,kw.

24,113

Advanced

48

(ovar* adj6 malignan*).mp,kw.

7601

Advanced

49

(ovar* adj6 metasta*).mp,kw.

5781

Advanced

50

(ovar* adj6 carcin*).mp,kw.

18,742

Advanced

51

(ovar* adj6 adenocarcin*).mp,kw.

2966

Advanced

52

(ovar* adj6 adeno-carcin*).mp,kw.

12

Advanced

53

(ovar* adj6 choriocarcin*).mp,kw.

217

Advanced

54

(granulosa adj6 cancer*).mp,kw.

54

Advanced

55

(granulosa adj6 tumo?r*).mp,kw.

2699

Advanced

56

(granulosa adj6 neoplas*).mp,kw.

173

Advanced

57

(granulosa adj6 malignan*).mp,kw.

142

Advanced

58

(granulosa adj6 metasta*).mp,kw.

111

Advanced

59

(granulosa adj6 carcin*).mp,kw.

118

Advanced

60

(granulosa adj6 adenocarcin*).mp,kw.

45

Advanced

61

(granulosa adj6 adeno-carcin*).mp,kw.

0

Advanced

62

OGCTs.mp,kw.

28

Advanced

63

HBOC.mp,kw.

650

Advanced

64

Luteoma*.mp,kw.

203

Advanced

65

Sertoli-Leydig*.mp,kw.

1039

Advanced

66

Thecoma*.mp,kw.

1013

Advanced

67

(theca* adj6 tumo?r*).mp,kw.

493

Advanced

68

(ovar* adj6 dysgerminoma?).mp,kw.

467

Advanced

69

androblastoma*.mp,kw.

321

Advanced

70

arrhenoblastoma*.mp,kw.

349

Advanced

71

arrheno-blastoma*.mp,kw.

1

Advanced

72

Meig*.mp,kw.

2152

Advanced

73

or/44-72

93,590

Advanced

74

exp Endometrial Neoplasms/

17,416

Advanced

75

(endometr* adj6 neoplas*).mp,kw.

17,866

Advanced

76

(endometr* adj6 cancer*).mp,kw.

15,307

Advanced

77

(endometr* adj6 tumo?r*).mp,kw.

5128

Advanced

78

(endometr* adj6 carcino*).mp,kw.

12,730

Advanced

79

(endometr* adj6 adenocarcin*).mp,kw.

5361

Advanced

80

(endometr* adj6 adeno-carcin*).mp,kw.

9

Advanced

81

(endometr* adj6 sarcoma*).mp,kw.

1230

Advanced

82

(endometr* adj6 malignan*).mp,kw.

2300

Advanced

83

(endometr* adj6 metast*).mp,kw.

1337

Advanced

84

(endometr* adj6 onco*).mp,kw.

370

Advanced

85

(endometr* adj6 choriocarcin*).mp,kw.

88

Advanced

86

or/74-85

31,774

Advanced

87

Uterine Cervical Neoplasms/

65,130

Advanced

88

(cervi* adj6 cancer*).mp,kw.

41,277

Advanced

89

(cervi* adj6 neoplas*).mp,kw.

69,153

Advanced

90

(cervi* adj6 tumo?r*).mp,kw.

7715

Advanced

91

(cervi* adj6 malignan*).mp,kw.

3006

Advanced

92

(cervi* adj6 metast*).mp,kw.

6612

Advanced

93

(cervi* adj6 onco*).mp,kw.

1280

Advanced

94

(cervi* adj6 carcin*).mp,kw.

24,588

Advanced

95

(cervi* adj6 adenocarcin*).mp,kw.

2945

Advanced

96

(cervi* adj6 adeno-carcin*).mp,kw.

9

Advanced

97

(cervi* adj6 squamous*).mp,kw.

7833

Advanced

98

(cervi* adj6 adenosquamous*).mp,kw.

211

Advanced

99

(cervi* adj6 adeno-squamous*).mp,kw.

2

Advanced

100

(cervi* adj6 sarcoma*).mp,kw.

661

Advanced

101

(cervi* adj6 small cell*).mp,kw.

364

Advanced

102

(cervi* adj6 large cell*).mp,kw.

78

Advanced

103

(cervi* adj6 neuroendocrine*).mp,kw.

195

Advanced

104

(cervi* adj6 neuro-endocrine*).mp,kw.

2

Advanced

105

(cervi* adj6 choriocarcin*).mp,kw.

112

Advanced

106

SCCC.mp,kw.

46

Advanced

107

or/87-106

90,890

Advanced

108

73 or 86 or 107

199,155

Advanced

109

exp Lymphocytes/

461,529

Advanced

110

lymphocyte?.mp,kw.

554,948

Advanced

111

(lymphoid adj2 cell?).mp,kw.

22,666

Advanced

112

(killer adj4 cell?).mp,kw.

51,337

Advanced

113

(nk adj2 cell?).mp,kw.

31,413

Advanced

114

(lak adj2 cell?).mp,kw.

2650

Advanced

115

b-lymphocyte?.mp,kw.

93,264

Advanced

116

t-lymphocyte?.mp,kw.

290,882

Advanced

117

b-lymphoid.mp,kw.

2219

Advanced

118

t-lymphoid.mp,kw.

1196

Advanced

119

(plasm adj2 cell?).mp,kw.

31

Advanced

120

plasmacyte?.mp,kw.

341

Advanced

121

(immune adj3 cell?).mp,kw.

58,743

Advanced

122

(immunocompetent adj2 cell?).mp,kw.

3494

Advanced

123

immnunocyte?.mp,kw.

0

Advanced

124

immnuno-cyte?.mp,kw.

0

Advanced

125

lymph cell?.mp,kw.

184

Advanced

126

null cell?.mp,kw.

3404

Advanced

127

immunological* competent cell?.mp,kw.

153

Advanced

128

immunoreactive cell?.mp,kw.

6231

Advanced

129

immuno-reactive cell?.mp,kw.

18

Advanced

130

prolymphocyte?.mp.

218

Advanced

131

pro-lymphocyte?.mp.

3

Advanced

132

or/109-131

648,538

Advanced

133

Neutrophils/

77,202

Advanced

134

neutrophil*.mp,kw.

135,327

Advanced

135

(cell? adj2 le).mp,kw.

868

Advanced

136

(leukocyte? adj3 polymorphonuclear).mp,kw.

14,471

Advanced

137

pmn granulocyte?.mp,kw.

52

Advanced

138

pmn leukocyte?.mp,kw.

400

Advanced

139

(poly morphou* adj2 granulocyte?).mp,kw.

0

Advanced

140

(polynuclear adj3 leukocyte?).mp,kw.

71

Advanced

141

or/133-140

139,999

Advanced

142

(neutrophil? adj6 lymphocyte?).mp,kw.

8790

Advanced

143

NLR.mp,kw.

1729

Advanced

144

132 and 141

26,722

Advanced

145

or/142-144

27,810

Advanced

146

exp Cohort Studies/

1,522,637

Advanced

147

exp Prognosis/

1,240,142

Advanced

148

exp Morbidity/

425,952

Advanced

149

exp Mortality/

309,548

Advanced

150

exp survival analysis/

214,369

Advanced

151

exp models, statistical/

311,009

Advanced

152

prognos*.mp,kw.

603,945

Advanced

153

predict*.mp,kw.

1,026,266

Advanced

154

course*.mp,kw.

467,535

Advanced

155

diagnosed.mp,kw.

361,373

Advanced

156

cohort*.mp,kw.

388,862

Advanced

157

death?.mp,kw.

646,834

Advanced

158

or/146-157

4,572,550

Advanced

159

108 and 145 and 158

64

Advanced

160

43 and 145 and 158

122

Advanced

161

159 or 160

184

Advanced

162

limit 161 to yr = “2013-Current”

85

Advanced

  1. aOvid MEDLINE®, 1946–April week 2 2016